Lauren Gilchrist Monovich

This inventor holds 12 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 8 EPO patents. Top assignee: Novartis Ag. Active years: 2007-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lauren Gilchrist Monovich. Retrieved from https://idiyas.com/inventor/lauren-gilchrist-monovich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12 (Patent Applications = 7)

% Patents Active = 83.3

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 11)

Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 21(Granted Patents)

Location History:

Summit, NJ (US) (2007)
Belmont, MA (US) (2012 - 2023)

Company Filing History:

12 out of 3,978

Novartis Ag

patents

Years Active: 2007-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12209144 - Cyclic peptides as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders (2025-01-28),

2. 11813306 - Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders (2023-11-14),

3. 11026993 - Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders (2021-06-08),

4. 9434754 - Use of an adrenal hormone-modifying agent (2016-09-06),

5. 9278969 - Organic compounds (2016-03-08),

6. 8835646 - Organic compounds (2014-09-16),

7. 8609862 - Use of an adrenal hormone-modifying agent (2013-12-17),

8. 8586782 - Phenylacetic acid derivatives (2013-11-19),

9. 8575160 - Imidazole derivatives as aldosterone synthase inhibitors (2013-11-05),

10. 8362294 - Phenylacetic acid derivatives (2013-01-29),

11. 8314097 - Organic compounds (2012-11-20),

12. 7202364 - Certain phenylacetic acids and derivatives (2007-04-10),

Title: The Innovative Contributions of Lauren Gilchrist Monovich

Introduction

Lauren Gilchrist Monovich is a prominent inventor based in Belmont, MA (US). She has made significant contributions to the field of biomedical research, particularly in the development of novel therapeutic agents. With a total of 12 patents to her name, her work has had a substantial impact on the treatment of metabolic disorders.

Latest Patents

Among her latest patents are innovative cyclic peptides that serve as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. These inhibitors are crucial for the treatment of lipid metabolism disorders. The disclosures relate to compounds that can effectively target PCSK9, which plays a vital role in cholesterol metabolism and other related diseases. The formulations include cyclic tetramer compounds that can be utilized in various pharmaceutical applications.

Career Highlights

Lauren has worked with notable organizations such as Novartis AG and the Friedrich Miescher Institute for Biomedical Research. Her experience in these prestigious institutions has allowed her to advance her research and contribute to groundbreaking discoveries in the field of metabolic disorders.

Collaborations

Throughout her career, Lauren has collaborated with esteemed colleagues, including Gary Michael Ksander and Erik Meredith. These partnerships have fostered a collaborative environment that has enhanced her research and innovation efforts.

Conclusion

Lauren Gilchrist Monovich's contributions to the field of biomedical research exemplify her dedication to innovation and the advancement of medical science. Her work continues to pave the way for new treatments that address critical health issues.

Profile summary based on public USPTO records.